STOCKS SINK WITH FED IN FOCUS, AMAZON EARNINGS ON DECK

Pot stocks trade higher on move to reclassify marijuana in the U.S.

Forte Biosciences, Inc. (FBRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Add to watchlist

0.7412

+0.0302

(+4.25%)

At close: 04:00PM EDT

Loading interactive chart...

Business Wire
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
DALLAS, March 18, 2024--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and provided a business update.
Business Wire
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
DALLAS, December 01, 2023--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules.
Business Wire
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
DALLAS, November 13, 2023--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced third quarter 2023 results and provided a business update.